# Anne‐Lise Kamper

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anne-lise-kamper/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,250 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 29 |
| i10-index | 66 |
| Last Known Institution | Rigshospitalet |
| OpenAlex ID | https://openalex.org/A5048371995 |
| ORCID iD | 0000-0001-7523-6569 |
| Works | 166 |

## Researcher papers

- [Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease](https://scholariq.org/papers/stroke-and-bleeding-in-atrial-fibrillation-with-chronic-kidney-disease/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease](https://scholariq.org/papers/net-clinical-benefit-of-antithrombotic-therapy-in-patients-with-atrial/)
- [Long‐term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis](https://scholariq.org/papers/long-term-mortality-and-renal-outcome-in-a-cohort-of-100-patients-with-lupus/)
- [Effect of Enalapril on the Progression of Chronic Renal Failure](https://scholariq.org/papers/effect-of-enalapril-on-the-progression-of-chronic-renal-failure/)
- [Progression Risk, Urinary Protein Excretion, and Treatment Effects of Angiotensin-Converting Enzyme Inhibitors in Nondiabetic Kidney Disease](https://scholariq.org/papers/progression-risk-urinary-protein-excretion-and-treatment-effects-of-angiotensin/)
- [The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease](https://scholariq.org/papers/the-effect-of-angiotensin-converting-enzyme-inhibitors-on-progression-of/)
- [Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy](https://scholariq.org/papers/effect-of-enalapril-on-haemoglobin-and-serum-erythropoietin-in-patients-with/)
- [Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease](https://scholariq.org/papers/reproducibility-of-pulse-wave-analysis-and-pulse-wave-velocity-determination-in/)
- [Risk of Infective Endocarditis in Patients with End Stage Renal Disease](https://scholariq.org/papers/risk-of-infective-endocarditis-in-patients-with-end-stage-renal-disease/)
- [Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study](https://scholariq.org/papers/moderate-antiproteinuric-effect-of-add-on-aldosterone-blockade-with-eplerenone/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)

## Researcher university

- [Rigshospitalet](https://scholariq.org/institutions/rigshospitalet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.